E-cadherin expression in acquired cholesteatoma.

Area of Science:

• Otology and Otolaryngology
• Cell Biology
• Immunohistochemistry

Background:

• Epithelial cell adhesion molecule E-cadherin is crucial for tissue architecture, cell communication, and immune cell migration.
• E-cadherin is present in cholesteatomas, but its expression patterns in relation to disease characteristics are not fully understood.

Purpose of the Study:

• To determine E-cadherin expression in acquired middle ear cholesteatomas.
• To analyze the relationship between E-cadherin expression and clinical/histological features of cholesteatomas.

Main Methods:

• Investigated E-cadherin expression in 30 acquired middle ear cholesteatoma samples using immunohistochemistry.
• Employed a semi-quantitative method to assess E-cadherin expression index.
• Utilized t-tests, Mann-Whitney U tests, and Spearman correlation for statistical analysis.

Main Results:

• Significant E-cadherin expression was observed on various immune cells, including CD1, CD3, CD4, CD8 lymphocytes, CD19/CD38 lymphocytes, mast cells, and antigen-presenting cells (Langerhans cells).
• Expression levels varied from significant to very highly significant (p < 0.005) on specific cell types.
• No statistically significant differences in E-cadherin expression were found based on cholesteatoma clinical or histological characteristics.

Conclusions:

• E-cadherin expression was uniform within the cholesteatoma matrix across all analyzed samples.
• The study concludes that E-cadherin expression does not differ based on the clinical or histological characteristics of acquired cholesteatomas.